News Home » Medical and Pharma » Sage shares surge as depression drug succeeds mid-stage trial

Around the World

Sage shares surge as depression drug succeeds mid-stage trial

James Bay 1 Dec 7
Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of…